The age-sex distributions and temporal trends in incidence of leukaemia and lymphoma from the Manchester Children's Tumour Registry (MCTR), 1954-1998, are reported. This 45-year study includes 1795 children, all of whom had a histologically and/or cytologically verified leukaemia or lymphoma. At the time of their diagnoses all the children were under 15 years of age and were resident in a geographically defined area of northwest England covered by the MCTR. Log-linear modelling identified significant linear increases in acute lymphoblastic leukaemia (ALL) (average annual increase 0.7%; P = 0.005) and in Hodgkin's disease (HD) (1.2%, P = 0.04), but not in acute myeloid leukaemia (AML), nor in non-Hodgkin's lymphoma (NHL). The increase in ALL was most pronounced amongst males, aged 1-4 years, and is likely to be due to precursor Bcell leukaemias. The increases in ALL and HD are discussed in relation to current hypotheses suggesting a role for infection. Additionally, a non-linear cohort effect was identified for NHL (P = 0.008), which may indicate the involvement of environmental factors other than infection. Leukemia (2001) 15, 1612-1618.
Introduction
The Manchester Children's Tumour Registry (MCTR) collects incidence data on all cancer in children, aged less than 15 years, from a defined geographical region of north-west England. Since multiple sources of ascertainment are used and nearly all cases of childhood cancer are diagnosed through the UK's publicly funded National Health Service, ascertainment is estimated to be very close to 100%, even during the early years of the registry. 1, 2 Since 1974 more than 90% of cases in the region have been managed at a single regional centre and even in the early years approaching half of the cases were treated in the centre, allowing for further crossreferencing. Reporting practice has not changed over the 45 years of the MCTR's existence. The registry retains histopathological material, and diagnostic review is periodically undertaken to ensure that changes in diagnostic practice and classification will not affect conclusions concerning changes in incidence rates over time.
The present analysis is based on MCTR data collected during a 45-year time period, 1954-1998, and updates a previous 35-year analysis. 3 That 35-year analysis identified statistically significant increases in the incidence of acute lymphoblastic leukaemia (ALL) and of Hodgkin's disease (HD), but not of acute myeloid leukaemia (AML) nor of non-Hodgkin's lymphoma (NHL).
The purpose of the present analysis, which includes an additional 10 years of data (1989) (1990) (1991) (1992) (1993) (1994) (1995) (1996) (1997) (1998) , is to examine whether the previously observed increases have continued or stabilised. In addition, we wished to establish whether any identified increasing time trends were real or artefactual; and age-period-cohort models 4, 5 were used to examine whether there were any irregular period or cohort effects. Such effects may provide clues to aetiology and can be used to formulate hypotheses.
Patients and methods
Full details of the methods employed by the MCTR are given elsewhere. [1] [2] [3] For each registered case, either a detailed abstract or copy of the medical record was stored. For the leukaemias, diagnoses were based on bone marrows and for the lymphomas, diagnoses were based on histopathological review. Biopsy material was circulated to a panel of pathologists to ensure diagnostic accuracy and is also stored so that diagnoses can be re-reviewed to incorporate any changes which might occur in international classification and in line with advances in technology.
Cases
All children, who were aged under 15 years and were resident in the MCTR region of north-west England when diagnosed with leukaemia or lymphoma during the 45-year period, 1954-1998, were included in this study. The data abstracted from the MCTR files for each case were: sex; age-group at diagnosis (a priori defined as Ͻ1 year, 1-4 years, 5-9 years, 10-14 years); time period of diagnosis (a priori defined as 1954-1958, 1959-1963, 1964-1968, 1969-1973, 1974-1978, 1979-1983, 1984-1988, 1989-1993, 1994-1998) ; and diagnostic group.
Diagnostic groups
The diagnostic groups were chosen prior to analysis. These were: acute lymphoblastic leukaemia (ALL), acute myeloid leukaemia (AML), Hodgkin's disease (HD), and non-Hodgkin's lymphoma (NHL). The case data were tabulated by age group, sex, diagnostic period (ie quinquennium) and diagnostic group simultaneously (Tables 1 and 2) .
Population estimates
Annual mid-year population estimates by sex and age group for the years 1954-1998, derived from the decennial censuses of England and Wales, and adjusted for births, deaths and 
Statistical analyses
Analyses were performed separately for each diagnostic group. Age group-, sex-and diagnostic period-specific annual incidence rates, per million population, were calculated. Incidence rates for the age-group 0-14 years (Tables 1 and 2) were age-standardised by the direct method using the world standard population. Chi-squared tests for heterogeneity between overall rates by time period and for a linear trend over time period were carried out 7 using the software packages EXCEL 8 and GLIM. 9 A much more sophisticated approach was adopted to examine further the patterns in incidence rates and quantify the magnitude of effects. Log-linear modelling was used 7 for each diagnostic group using the computer package GLIM. 9 Statistical models were fitted to the tabulated case data in which it is assumed that the number of cases in each category follows a Poisson distribution, with the mean equal to the product of the person-years at risk and the incidence rate, and where the incidence rate is a product of factors depending on age group, sex, diagnostic period and interactions between these. The models took the form
where a i is the effect of age-group i, s j is the effect of sex j, p k is the effect of period k, (a.s) ij is the effect of the interaction between age-group i and sex j, (a.p) ik is the effect of the interaction between age-group i and period k, (s.p) jk is the effect Leukemia of the interaction between sex j and period k, and r ijk is the incidence rate.
The variation of incidence rates over time was of special interest and, in particular, whether or not similar temporal trends for both sexes and all age groups were displayed, or if a constant proportional increase from one time period to the next (ie a linear trend on a log scale) was exhibited. Maximum likelihood estimates of relative risks and corresponding 95% confidence intervals were calculated from the parameters of these models. Non-linear period effects and non-linear cohort effects were studied using the method of Clayton and Schifflers. 4, 5, 10 This method uses age-period-cohort models, given by E[ln r ij ] = a i + p j + c k , where A is the number of age-groups, a i is the effect of age-group i, p j is the effect of period j, r ij is the incidence rate, k = A − i + j, and c k is the effect of birthcohort k. Three age-groups: (1) 
Results
Between 1954 and 1998, the MCTR received registrations for 1795 patients with leukaemia or lymphoma including 1119 cases of ALL, 258 of AML, 173 of HD and 195 of NHL. There were 35 cases of other and unspecified leukaemias and 15 cases of other and unspecified lymphoreticular neoplasms. These 50 cases were excluded from the analyses. Table 1 shows the numbers of actual cases by age-group, sex and diagnostic group for the entire 45-year period (1954-1998) with the average age-specific annual incidence rates (per million population) and the world standardised annual incidence rates (per million population). Table 2 presents numbers of cases and world standardised annual incidence rates (per million population) by diagnostic period, together with the results of chi-squared tests for heterogeneity and trend over time.
Table 2
Number of cases and age-standardised annual incidence, per million population, of leukaemias and lymphomas by diagnosis, time period and sex, 1954-1998 1954-1958 1959-1963 1964-1968 1969-1973 1974-1978 1979-1983 1984-1988 1989-1993 1994-1998 Relative risk (RR) estimates, together with 95% confidence intervals (CI), were obtained from log-linear modelling, for females compared with males. Table 3 shows relative risk estimates with 95% confidence intervals, obtained from log-linear modelling, for each age-group compared with the age-group with the highest incidence rate. Table 4 contains estimates of the effect of each time period relative to the period with the highest rate, and Table 5 contains estimates of the effect of each birth cohort relative to the birth cohort with the highest rate. The results of all these analyses are presented below by disease group. 
ALL
There was a peak in incidence at ages 1-4 years (Tables 1 and  3 ). This peak was evident throughout the 45-year period. There was a significant excess of male cases (female:male RR = 0.75; 95% CI: 0.66 to 0.84). Overall, ALL showed an increasing trend of 3.3% per quinquennium (95% CI: 1.0% to 5.7%), giving an average increase of 0.7% per annum (95% CI: 0.2% to 1.1%), during the 45-year time period. For agegroups 5-9 years and 10-14 years, there was a fairly consistent excess of male over female cases. However, for the 1-4 year olds, there was a male excess for the years 1959 until 1983, but for the periods 1984-1988 and 1994-1998 there was an excess of female cases. Numbers were very small for children aged less than 1 year with similar rates in males and females. The increase in incidence for ALL was largely accounted for by the 1-4 year olds. Further statistical modelling of the incidence rates for males and females, during the period 1979-1998, was undertaken. This showed that the recent average rate of increase for males, aged 1-4, was 2.4% per annum, whilst the rate of increase for females, aged 1-4, was 2.9% per annum.
AML
Incidence rates were highest in those aged Ͻ1 year (Tables 1  and 3 ). There was a marginally significant excess of female cases (female:male RR = 1.25; 95% CI: 0.98 to 1.60). There was little evidence of any change in incidence rate over time. During the 45-year time period, there was an increasing trend of 1.4% per quinquennium, but this did not approach significance (95% CI: −3.4% to 6.3%).
HD
There was a peak in incidence at ages 10-14 years (Tables 1  and 3) , with no female cases aged less than 5 years, and no male cases aged less than 1 year (Table 1) . There was a consistent male excess of cases, although this varied by age-group (female:male RR = 0.28; 95% CI: 0.14 to 0.56 for the 5-9 year olds, and RR = 0.55; 95% CI: 0.37 to 0.82 for the 10-14 year olds). Hodgkin's disease increased at a rate of 6.4% per quinquennium (95% CI: 0.3% to 12.8%) , giving an average increase of 1.2% per annum (95% CI: 0.1% to 2.4%), during the 45-year time period. Analysis of HD by subtype showed that there were 55 cases of 'nodular sclerosis', 60 cases of 'mixed cellularity', 45 cases of 'lymphocyte predominant', seven cases of 'lymphocyte depleted' and six cases which were not otherwise specified. Statistical modelling was done on those subtypes with more than 50 cases ('nodular sclerosis' and 'mixed cellularity'). An annual increase of 6.6% per annum (95% CI: 4.1% to 9.2%) was identified only for the 'nodular sclerosis' subtype. There was little evidence of any change in the incidence rate of the 'mixed cellularity' subtype over time. During the 45-year time period, there was a decreasing trend of −0.9% per annum but this did not approach significance (95% CI: −2.9% to 1.1%)
NHL
This disease was very rare in those aged less than 1 year (Tables 1 and 3) . Male rates were double those for females (female: male RR = 0.53; 95% CI: 0.39 to 0.71). There was little evidence of any change in incidence rate over time. During the 45-year time period, there was an increasing trend of 1.0% per quinquennium, but this did not approach significance (95% CI: −4.4% to 6.7%). However, there was a statistically significant non-linear cohort effect (P = 0.008). There was a high rate for a short period for those born around 1958-1959 and a high rate for a longer period for those born around 1973-1974 (Table 5) .
Discussion
This new analysis for 45 years of incidence data, confirms a continuing temporal increase for childhood ALL, since the age-standardised rate for 1989-1998 is 31.7 per million person years, whilst for 1979-1988 it is 28.8 per million person years. Also, for HD, a continued upward trend has been found. However, the rate of increase in HD is less than previously reported, due to a paucity of cases in the period 1989-1993. Again no significant evidence for changes in incidence rates for AML and NHL was found. For the first time in the MCTR data, a non-linear cohort effect has been demonstrated for NHL. There are few recent studies of incidence trends from other countries. ALL is known to have increased in incidence in the United States and Europe until the 1980's. Data for the period 1974-1991 from the United States Surveillance, Epidemiology and End Results Program (SEER) 11 showed an increase in the incidence of childhood ALL, stable rates for AML amongst whites, but an increase in AML amongst African-Americans. In the same study, data for HD and NHL showed stable rates amongst both whites and African-Americans. 11 A recent study of childhood NHL, using data from nine European countries, 12 has shown a small increase of 0.8% per annum over the 21-year period, . Thus, the most recent MCTR data show similar trends to those observed in the USA up to 1991 for ALL, AML and NHL but not for HD. Unlike the Europeanwide study, 12 there was no evidence for a temporal increase in NHL in the MCTR data. However, our study looked at a 45-year time span, whereas the European-wide study examined only 21 years of data. Also, the incidence trends differed markedly between the nine European registries included in the study, and diagnostic artefact may have, at least in part, a role to play in the observed temporal changes.
In the present study, the increase in ALL was mainly due to an increase in incidence amongst 1-4 year olds. It is very likely to be solely due to the precursor B-cell subtype (common-ALL). Immunophenotypic subtype data have only been available since 1980 and a sub-analysis of ALL by subtype from our region 13 has shown that in recent years the increase is indeed specifically due to the common-ALL subtype in those aged 1-4 years. A space-time clustering analysis of MCTR leukaemia data has shown significant clustering of cases of ALL for ages 0-4 years 14 and an analysis of seasonal variation, for the same data, has revealed a significant seasonal pattern in cases of common-ALL, aged 0-14 years. 15 The present analysis has shown that the increase in female rates has been more rapid than in male rates. A study of HLA haplotypes in common-ALL has shown that a specific DQA1/DQB1 haplotype is associated with susceptibility in males, but not in females. 16 Together these results and the current data on incidence trends support the hypothesis that common-ALL is aetiologically linked to delayed exposure to common infections. 17 In contrast to ALL, AML has displayed stable incidence rates over the 45-year period and, from previous studies based on the MCTR, 14, 15 has shown neither seasonal variation nor space-time clustering. Also, in further contrast to ALL, there was a slight female excess of cases for AML. Therefore different factors and/or mechanisms may be involved in the aetiology of AML. The constant incidence level over time suggests that any environmental agents that contribute to the aetiology must have been present at a constant level for many years.
There was a male excess amongst observed cases of HD (2.58 male:1 female), with the greatest difference occurring in those aged 1-4 years (15 male cases, no female cases). The increase of 1.2% per annum for HD contrasts with the 1.6% per annum increase reported for . 3 The increase in HD is specifically due to a large increase in the number of cases of the 'nodular sclerosis' subtype. The reasons for the increase are not clear. The 'nodular sclerosis' subgroup is responsible for the young adult peak in HD and an infectious aetiology has been suggested. It is biologically plausible to postulate that an infectious aetiology also applies to childhood cases of the 'nodular sclerosis' subgroup. No candidate agent has been reliably identified, but the Epstein-Barr virus (EBV) has been considered as a putative aetiological agent in HD for many years. EBV has been detected in childhood cases of HD. 18, 19 However, in these two studies it was found to be present in most cases of the 'mixed cellularity' subtype, but only in some of the cases of the 'nodular sclerosis' subtype. Since the increase found from the MCTR data is confined to the 'nodular sclerosis' subgroup, the pattern is consistent with exposure to an infectious agent other than EBV, although it is possible that EBV may be a co-factor in some cases. The pattern of exposure to such infections is likely to be related to socio-economic status (ie deprivation) and ethnic group. This contrasts with common-ALL, where increased incidence is associated with higher living standards. An additional study based on the MCTR series 15 has found a very strong seasonal association with the onset of HD. This finding is consistent with a possible role for infections. It is planned, as a separate study, to examine the geographical distribution of HD in the MCTR area. Such a study may be able to elucidate differences in the incidence of HD between ethnic groups and between levels of deprivation. We would hypothesise that higher incidence will occur in the poorer ethnic groups and the most deprived areas. If birth rates and/or migration into these areas are differentially greater than the most affluent areas, then the increase in incidence of HD may be explained by these factors.
In common with HD there was a male excess for observed cases of NHL (1.93 male:1 female), being most pronounced in those aged 1-4 years (2.26 male: 1 female). In contrast to HD, there have been no overall changes in the rates of NHL over the 45-year period and, in our previous study, no seasonal variation was observed. 15 However, a non-linear cohort effect has been identified for NHL, attributable to excess rates for those born in four birth cohorts, centred on the years 1958/1959, 1968/1969, 1973/1974 and 1978/1979 . These excess rates would point to one or more environmental exposures particularly affecting children born in the four birth cohorts. Such exposures are more likely to be non-infectious because they would affect a large proportion of the children born in these cohorts only around the time of birth. The respective environmental factor(s) may not necessarily be the same for different cohorts. A closer examination of demographic characteristics associated with cases included in the four birth cohorts and their parents may suggest possible lines of investigation.
Around the mid-point of the study period there was a 10% reduction in population coverage due to boundary changes. However, we believe that incidence trends were not influenced by these boundary changes. This is supported by the following three arguments. First of all, the increases in incidence were confined to particular diagnostic subtypes (ALL and 'nodular sclerosis' HD), whereas there were no significant changes in the rates for AML and NHL. An artefactual effect would either cause an increase for all diagnostic groups, or a decrease in some diagnostic groups. Secondly, increases for Leukemia ALL and HD, preceded the boundary changes as demonstrated from previous studies. 3, 20 Thirdly, recent increases in the incidence of precursor B-cell ALL have been identified during the period 1980-1998, exclusively based on the current region. 13 Together with the present study these earlier studies demonstrate that the upwards trends began in the pre-1974 period and continued after the boundary changes.
We have to consider whether the increased incidence rates observed in the present study can be attributed to better reporting practice. Reporting practices have not greatly changed between 1954 and 1998 and, given that the increases are in specific diagnostic groups, reporting bias is unlikely to be responsible for these increases. Does diagnostic artefact have a role to play? Changes in diagnostic practice may artefactually change rates but, from 1954 onwards, the MCTR cases have all been reviewed centrally and re-reviewed as appropriate. Uniform criteria have, therefore, been applied across the 45-year period with respect to diagnostic classification. We infer that the increases observed for the MCTR data are real.
Conclusions
There has been a continued increase in ALL, mainly attributable to those aged 1-4 years. An increase in HD incidence is apparent across the entire time period due mainly to cases of the nodular sclerosis subtype. AML and NHL both exhibit stable rates. Age-period-cohort modelling has not revealed any non-linear period effects, and has identified non-linear cohort effects for NHL only. The lack of such effects in ALL, AML and HD indicates that the pattern of exposure to putative aetiological agents is not confined to specific years or ages. However, for NHL, the finding indicates that the aetiological factors are acting around the time of birth, or at some constant age, either pre-or post-natally, but the effect(s) may differ for children born in different years.
Although there may be aetiological factors which are common to all childhood leukaemias or lymphomas, the different patterns of incidence observed over a 45-year period suggest that predominating aetiological factors and mechanisms differ according to diagnostic group. Detailed studies of incidence patterns can provide pointers for the construction of hypotheses to be tested in subsequent analytical studies of aetiology.
